In this issue:
Breast cancer survival in sub-Saharan Africa
Treatment after progression on CDK4/6 inhibitors for hormone receptor+, HER2– metastatic breast cancer
First-line treatments and survival across sociodemographic groups in metastatic TNBC
PPIs with CDK4/6 inhibitors in hormone receptor+ metastatic breast cancer
Prognostic value of depression in hormone-responsive early breast cancer
Adding intermittent energy restriction to resistance exercise during chemotherapy for advanced breast cancer
Exercise during neoadjuvant chemotherapy for breast cancer: tumour response
Association of low-dose aspirin with breast cancer recurrence
Gedatolisib plus palbociclib-letrozole in hormone receptor+, HER2– advanced breast cancer
Long term outcomes of breast primary sarcomas and malignant phyllodes tumours
Please login below to download this issue (PDF)